BiotechTube
Home/LadRx/John D. Mendelson
JD

John D. Mendelson

Former CSO & Founder

LadRx

Therapeutic Areas

Oncology

LadRx Pipeline

DrugIndicationPhase
Aldoxorubicin (LADR-7)Soft Tissue SarcomaPhase 3
LADR PlatformVarious CancersPreclinical

Leadership Team at LadRx

SG
Stephen G. Marcus
Former CEO & Director
DJ
David J. Haen
Former CFO & Secretary
View full LadRx profile